These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3567260)

  • 21. Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics.
    Dinan TG
    Psychol Med; 1987 Nov; 17(4):875-81. PubMed ID: 2893407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
    Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S
    Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid tranquilization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine.
    Man PL; Chen CH
    Psychosomatics; 1973; 14(1):59-63. PubMed ID: 4605009
    [No Abstract]   [Full Text] [Related]  

  • 25. [Plasma levels of antipsychotics and the severity of side-effects in the treatment of schizophrenia exacerbation].
    Potanin SS; Burminskiy DS; Morozova MA; Platova AI; Baymeeva NV; Miroshnichenko II
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(11):40-46. PubMed ID: 26978050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of neuroleptics (haloperidol and chlorpromazine) on the pharmacokinetics of valproic acid in schizophrenic patients.
    Ishizaki T; Chiba K; Saito M; Kobayashi K; Iizuka R
    J Clin Psychopharmacol; 1984 Oct; 4(5):254-61. PubMed ID: 6149238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychotropic drugs in the management of psychiatric emergencies.
    Ketai R
    Postgrad Med; 1975 Oct; 58(4):87-93. PubMed ID: 1161668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolution of chlorpromazine-induced pigmentation with haloperidol substitution.
    Thompson TR; Lal S; Yassa R; Gerstein W
    Acta Psychiatr Scand; 1988 Dec; 78(6):763-5. PubMed ID: 3223334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differences.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):115-21. PubMed ID: 1103206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
    Levinson I; Levine S
    Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse drug reactions experienced by out-patients taking chlorpromazine or haloperidol at Zomba Mental Hospital, Malawi.
    Chikowe I; Domingo M; Mwakaswaya V; Parveen S; Mafuta C; Kampira E
    BMC Res Notes; 2019 Jul; 12(1):376. PubMed ID: 31262359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haloperidol versus chlorpromazine for treatment of schizophrenia.
    Leucht C; Kitzmantel M; Chua L; Kane J; Leucht S
    Schizophr Bull; 2008 Sep; 34(5):813-5. PubMed ID: 18658127
    [No Abstract]   [Full Text] [Related]  

  • 33. The characteristics of side-effects of bromperidol in schizophrenic patients.
    Yasui-Furukori N; Kondo T; Ishida M; Tanaka O; Mihara K; Kaneko S; Otani K
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):103-6. PubMed ID: 11929578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulpiride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effect, side effects and plasma concentrations.
    Gerlach J; Behnke K; Heltberg J; Munk-Anderson E; Nielsen H
    Br J Psychiatry; 1985 Sep; 147():283-8. PubMed ID: 3904885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased plasma vasopressin and atrial natriuretic peptide in chronic schizophrenic patients during abdominal surgery.
    Kudoh A; Kudo M; Ishihara H; Matsuki A
    Neuropsychobiology; 1998; 37(4):169-74. PubMed ID: 9648123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of chlorpromazine and clozapine on plasma concentrations of haloperidol in a patient with schizophrenia.
    Allen SA
    J Clin Pharmacol; 2000 Nov; 40(11):1296-7. PubMed ID: 11075316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia.
    Battaglia J; Houston JP; Ahl J; Meyers AL; Kaiser CJ
    Clin Ther; 2005 Oct; 27(10):1612-8. PubMed ID: 16330297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof.
    Suzuki H; Gen K; Inoue Y
    J Psychopharmacol; 2013 Apr; 27(4):396-400. PubMed ID: 23427194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytolytic hepatitis during treatment with phenothiazines: apropos of a case].
    Mesure G; Bayle F; Vanelle JM; Olié JP; Lôo H
    Encephale; 1996; 22(5):388-90. PubMed ID: 9035996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.